Urology
 |
|
19 february 2020 23:00:05 |
| Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy (European Urology Oncology) |
|
Tweet Recurrent metastatic prostate cancer is frequently detected with prostate-specific membrane antigen positron emission tomography in men treated with radiotherapy, before meeting the Phoenix criteria for biochemical recurrence. These compelling findings call for re-evaluation of the Phoenix criteria, as timely detection of recurrences might refine salvage and/or adjuvant therapies. |
| 188 viewsCategory: Oncology, Urology |
 Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile (European Urology Oncology)Re: Karl H. Tully, David-Dan Nguyen, Peter Herzog, et al. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2019.08.003 (European Urology Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page